# Ketamine Treatment of Youth Suicide Attempters

> **NCT04763343** · PHASE3 · RECRUITING · sponsor: **Tatiana Falcone, MD** · enrollment: 60 (estimated)

## Conditions studied

- Suicide, Attempted

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **DRUG:** Saline
- **BEHAVIORAL:** CAMS Therapy

## Key facts

- **NCT ID:** NCT04763343
- **Lead sponsor:** Tatiana Falcone, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-27
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04763343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04763343, "Ketamine Treatment of Youth Suicide Attempters". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04763343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*